指南与共识中枢神经肿瘤放疗放疗物理与技术

ESTRO-EANO指南:胶质母细胞瘤靶区勾画与放疗细节

ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
指南 / 共识 · Radiother Oncol · 2023-04-13

该指南由ESTRO指南委员会联合EANO的14位欧洲专家,通过两步改良Delphi法讨论胶质母细胞瘤靶区勾画证据。EORTC共识推荐基于术后增强T1异常区定义单一CTV,采用各向同性外扩且无需锥形缩野;PTV外扩取决于面罩系统与IGRT,使用IGRT时通常不超过3 mm。

要点

  • EORTC共识推荐基于术后增强T1异常区定义单一CTV,各向同性外扩且无需锥形缩野。
  • PTV外扩应基于个体面罩系统和可用IGRT流程,使用IGRT时通常不超过3 mm。
  • 指南讨论了治疗前步骤与固定、标准及新型影像技术的靶区勾画以及计划技术与分次方案等技术方面。

核心结论

  • EORTC共识推荐基于术后增强T1异常区定义单一临床靶区,采用各向同性外扩且无需锥形缩野。
  • 建议基于个体面罩系统和可用IGRT流程确定PTV外扩,使用IGRT时通常不超过3 mm。

研究设计与样本

  • ESTRO指南委员会与ESTRO临床委员会和EANO密切协作确定14位欧洲专家,讨论并分析当代胶质母细胞瘤靶区勾画证据。
  • 专家参与两步改良Delphi流程以处理开放问题。

主要发现

  • 识别并讨论了治疗前步骤与固定、靶区勾画及标准与新型影像技术使用、计划技术和分次方案等技术方面等关键问题。
  • 基于EORTC推荐,针对切除腔和T1序列残余强化区并加15 mm缩减外扩,呈现了特殊情况及相应潜在调整。

关键数值与推荐

  • EORTC共识推荐基于术后增强T1异常区定义单一临床靶区,采用各向同性外扩且无需锥形缩野。
  • 建议基于个体面罩系统和可用IGRT流程确定PTV外扩,使用IGRT时通常不超过3 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Target delineation in glioblastoma is still a matter of extensive research and debate. This guideline aims to update the existing joint European consensus on delineation of the clinical target volume (CTV) in adult glioblastoma patients. MATERIAL AND METHODS: The ESTRO Guidelines Committee identified 14 European experts in close interaction with the ESTRO clinical committee and EANO who discussed and analysed the body of evidence concerning contemporary glioblastoma target delineation, then took part in a two-step modified Delphi process to address open questions. RESULTS: Several key issues were identified and are discussed including i) pre-treatment steps and immobilisation, ii) target delineation and the use of standard and novel imaging techniques, and iii) technical aspects of treatment including planning techniques and fractionation. Based on the EORTC recommendation focusing on the resection cavity and residual enhancing regions on T1-sequences with the addition of a reduced 15 mm margin, special situations are presented with corresponding potential adaptations depending on the specific clinical situation. CONCLUSIONS: The EORTC consensus recommends a single clinical target volume definition based on postoperative contrast-enhanced T1 abnormalities, using isotropic margins without the need to cone down. A PTV margin based on the individual mask system and IGRT procedures available is advised; this should usually be no greater than 3 mm when using IGRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Niyazi M, Andratschke N, Bendszus M, et al. ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol. 2023. PMID: 37059335. doi:10.1016/j.radonc.2023.109663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。